Identifying lung injury subtypes to guide treatment
Part of Lungs & breathing clinical trials.
This study looks at different patterns in patients with a severe lung condition called ARDS, to better understand why some respond to treatments differently. You may help doctors learn how to personalize care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old.
- You have a diagnosis of a severe lung injury called ARDS (based on the 2023 global definition).
- You or your legal representative agree to join the study and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at different types of inflammation in patients with Acute Respiratory Distress Syndrome (ARDS), a serious lung condition. It aims to find which treatments work best for each subtype.
This study examines lung fluid samples and imaging scans from patients on breathing machines to better understand acute respiratory distress syndrome (ARDS), a serious lung condition. Researchers hope this will help doctors diagnose and treat ARDS more effectively in the future.
This study collects health information from ICU patients with or at high risk for ARDS to better understand the condition and develop a tool to help doctors make decisions. It may not directly help you, but it could improve care for future patients.
This study looks for markers in the blood and signs of air trapped in the lung tissue of people with acute respiratory distress syndrome (ARDS). It uses CT scans to understand why air leaks happen and if certain lab tests can predict them.
This study looks at the real-world features, treatments, and outcomes of people with acute respiratory distress syndrome (ARDS), a serious lung condition that makes it hard to breathe. If you are on certain types of breathing support and meet the oxygen and lung scan criteria, your participation may help improve care for others with this condition.
This study is for patients in the ICU with ARDS (a severe lung condition). It looks at biomarkers (special substances in your blood) to help understand different types of ARDS. You do not receive any treatment, but you help researchers learn more about the disease.
Hear when a new Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.